424 related articles for article (PubMed ID: 28137813)
21. Risk factors for treatment failure in patients receiving vancomycin for hospital-acquired methicillin-resistant Staphylococcus aureus pneumonia.
Aston JL; Dortch MJ; Dossett LA; Creech CB; May AK
Surg Infect (Larchmt); 2010 Feb; 11(1):21-8. PubMed ID: 19689198
[TBL] [Abstract][Full Text] [Related]
22. No Outbreak of Vancomycin and Linezolid Resistance in Staphylococcal Pneumonia over a 10-Year Period.
Yayan J; Ghebremedhin B; Rasche K
PLoS One; 2015; 10(9):e0138895. PubMed ID: 26398276
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus and its antibiotic susceptibility pattern in healthcare workers at Namazi Hospital, Shiraz, Iran.
Askarian M; Zeinalzadeh A; Japoni A; Alborzi A; Memish ZA
Int J Infect Dis; 2009 Sep; 13(5):e241-7. PubMed ID: 19269873
[TBL] [Abstract][Full Text] [Related]
24. Effect of rapid methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction screening on vancomycin use in the intensive care unit.
Diep C; Meng L; Pourali S; Hitchcock MM; Alegria W; Swayngim R; Ran R; Banaei N; Deresinski S; Holubar M
Am J Health Syst Pharm; 2021 Dec; 78(24):2236-2244. PubMed ID: 34297040
[TBL] [Abstract][Full Text] [Related]
25. Predictive Value of the Methicillin-Resistant
Stodghill J; Finnigan A; Newcomb AB; Lita E; Liu C; Teicher E
Surg Infect (Larchmt); 2021 Nov; 22(9):889-893. PubMed ID: 33872057
[No Abstract] [Full Text] [Related]
26. Daily practice and prognostic factors for pneumonia caused by methicillin-resistant Staphylococcus aureus in Japan: A multicenter prospective observational cohort study.
Miyazaki T; Yanagihara K; Kakeya H; Izumikawa K; Mukae H; Shindo Y; Yamamoto Y; Tateda K; Tomono K; Ishida T; Hasegawa Y; Niki Y; Watanabe A; Soma K; Kohno S
J Infect Chemother; 2020 Feb; 26(2):242-251. PubMed ID: 31575499
[TBL] [Abstract][Full Text] [Related]
27. Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia.
Dangerfield B; Chung A; Webb B; Seville MT
Antimicrob Agents Chemother; 2014; 58(2):859-64. PubMed ID: 24277023
[TBL] [Abstract][Full Text] [Related]
28. Evaluating Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction Nasal Screening as a Tool for Antimicrobial Stewardship.
Bono K; Caceda JA; Zhai M; Horng H; Goldstein C; Sifri Z; Cennimo D; Glass NE
J Surg Res; 2023 Mar; 283():1047-1052. PubMed ID: 36914995
[TBL] [Abstract][Full Text] [Related]
29. What is the best therapeutic approach to methicillin-resistant Staphylococcus aureus pneumonia?
Peyrani P; Ramirez J
Curr Opin Infect Dis; 2015 Apr; 28(2):164-70. PubMed ID: 25692268
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of linezolid versus a pharmacodynamically optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureus.
Docobo-Pérez F; López-Rojas R; Domínguez-Herrera J; Jiménez-Mejias ME; Pichardo C; Ibáñez-Martínez J; Pachón J
J Antimicrob Chemother; 2012 Aug; 67(8):1961-7. PubMed ID: 22532466
[TBL] [Abstract][Full Text] [Related]
31. Methicillin-resistant Staphylococcus aureus Nasal Carriage Among Patients Admitted at Shaqra General Hospital in Saudi Arabia.
Alhussaini MS
Pak J Biol Sci; 2016; 19(5):233-238. PubMed ID: 29023028
[TBL] [Abstract][Full Text] [Related]
32. Active identification of patients who are methicillin-resistant Staphylococcus aureus colonized is not associated with longer duration of vancomycin therapy.
Acuna-Villaorduna C; Branch-Elliman W; Strymish J; Gupta K
Am J Infect Control; 2017 Oct; 45(10):1081-1085. PubMed ID: 28629753
[TBL] [Abstract][Full Text] [Related]
33. Nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus treated with linezolid or vancomycin: A secondary economic analysis of resource use from a Spanish perspective.
Rello J; Nieto M; Solé-Violán J; Wan Y; Gao X; Solem CT; De Salas-Cansado M; Mesa F; Charbonneau C; Chastre J
Med Intensiva; 2016 Nov; 40(8):474-482. PubMed ID: 27061776
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs.
Martinez-Olondris P; Rigol M; Soy D; Guerrero L; Agusti C; Quera MA; Li Bassi G; Esperatti M; Luque N; Liapikou M; Filella X; Marco F; de la Bellacasa JP; Torres A
Crit Care Med; 2012 Jan; 40(1):162-8. PubMed ID: 21926613
[TBL] [Abstract][Full Text] [Related]
35. Rapid MRSA PCR on respiratory specimens from ventilated patients with suspected pneumonia: a tool to facilitate antimicrobial stewardship.
Trevino SE; Pence MA; Marschall J; Kollef MH; Babcock HM; Burnham CD
Eur J Clin Microbiol Infect Dis; 2017 May; 36(5):879-885. PubMed ID: 28004323
[TBL] [Abstract][Full Text] [Related]
36. The ZEPHyR study: a randomized comparison of linezolid and vancomycin for MRSA pneumonia.
Chavanet P
Med Mal Infect; 2013 Dec; 43(11-12):451-5. PubMed ID: 24238896
[TBL] [Abstract][Full Text] [Related]
37. Clinical utility of a nasal swab methicillin-resistant Staphylococcus aureus polymerase chain reaction test in intensive and intermediate care unit patients with pneumonia.
Giancola SE; Nguyen AT; Le B; Ahmed O; Higgins C; Sizemore JA; Orwig KW
Diagn Microbiol Infect Dis; 2016 Nov; 86(3):307-310. PubMed ID: 27591173
[TBL] [Abstract][Full Text] [Related]
38. Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
Segarra-Newnham M; Church TJ
Ann Pharmacother; 2012 Dec; 46(12):1678-87. PubMed ID: 23232021
[TBL] [Abstract][Full Text] [Related]
39. Clinical utility of methicillin-resistant Staphylococcus aureus nasal PCR to streamline antimicrobial use in treatment of diabetic foot infection with or without osteomyelitis.
Harb G; Hopkins T; Yang L; Morneau K; Cadena-Zuluaga J; Walter E; Frei C
BMC Infect Dis; 2023 May; 23(1):297. PubMed ID: 37147579
[TBL] [Abstract][Full Text] [Related]
40. Trimethoprim/sulfamethoxazole versus vancomycin in the treatment of healthcare/ventilator-associated MRSA pneumonia: a case-control study.
Eliakim-Raz N; Hellerman M; Yahav D; Cohen J; Margalit I; Fisher S; Zusman O; Shaked H; Bishara J
J Antimicrob Chemother; 2017 Mar; 72(3):882-887. PubMed ID: 27999052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
